

Overview
Welcome to the Hoover Lab — a translational research lab in the Division of Rheumatology, Inflammation, & Immunity at Brigham and Women’s Hospital and Harvard Medical School in Boston. Based in the Hale Building for Transformative Medicine in Longwood, we combine cutting-edge technology with clinical access to drive discoveries that translate into new therapies for autoimmune disease.
Our facility includes a cellular profiling hub (single-cell droplet and spatial transcriptomics), flow cytometry, histopathology, molecular imaging, and a mouse vivarium—tools that empower high-resolution study of immune cells in human tissue and preclinical models. We emphasize interdisciplinary collaboration with direct links to Brigham patient clinics and Harvard Medical School investigators.
Mission
We pursue a bed-to-bench translational strategy to identify and validate novel therapeutic targets in autoimmune diseases, with a focus on macrophage-driven mechanisms of tissue injury and repair in lupus nephritis and rheumatoid arthritis. Our goal is to reveal actionable biology that accelerates next-generation drug development.



Dr. Hoover is a rheumatologist and translational scientist specializing in autoimmune diseases. He serves as Director of Translational Research in Lupus Nephritis and Associate Director of Basic Science, and he co-leads the Lupus Clinic in the Division of Rheumatology, Immunity, and Inflammation at Brigham and Women’s Hospital. He earned his MD and PhD in Molecular and Cellular Physiology from Stanford University, completed his rheumatology training at Brigham and Women’s Hospital, and conducted postdoctoral research at the Broad Institute of MIT and Harvard.

Dr. Han is a post-doctoral researcher studying macrophage-stromal interactions that drive repair and injury in lupus nephritis. His work includes developing LN-associated macrophage and 3D kidney models for personalized lupus nephritis research. He utilizes CRISPR-Cas9 genetic screening to identify key regulators involved in macrophage differentiation and activation.

Dr. Roy is a postdoctoral researcher investigating injury‑associated monocytes and macrophages in autoimmune disease. Using mouse models of lupus nephritis, she employs genetic, pharmacologic, and antibody‑mediated approaches to perturb these cells and define their impact on immune responses and disease progression.

Raghav is a Bioinformatician in the Hoover and Gravallese Labs, where his research focuses on autoimmune diseases, particularly lupus nephritis and rheumatoid arthritis. By utilizing both human data and mouse models, he aims to uncover shared disease mechanisms related to lupus nephritis. His work integrates bulk and single-cell multiomics with spatial transcriptomics to identify disease drivers, map altered molecular pathways, and enhance our understanding of immune changes, particularly the role of macrophages in inflammation and tissue repair. Additionally, he highlights potential therapeutic targets for treating these conditions.

Megan is an Instructor in Medicine at Brigham and Women’s Hospital, Harvard Medical School, and an ANRF Gale “Morrie” Granger Fellow. She is a translational rheumatology researcher specializing in myeloid functions in Rheumatoid Arthritis, with interests in immunometabolism and early disease biomarkers. Megan earned her BSc in Biomedical, Health, and Life Sciences from University College Dublin and completed her PhD at Trinity College Dublin as an Irish Research Council Scholar. In 2022, she joined Harvard’s Gravallese lab as a visiting research fellow and now as a postdoctoral fellow, studying SPP1+ macrophages and the joint microenvironment's impact on trained immunity. She aims to further explore the interactions between metabolism, bone, and the immune system in RA. She is a research associate with in the Hoover Lab, providing important insights into macrophage.
A population-scale transcriptional atlas of blood and tissue in lupus nephritis.
Sugiarto NW, Gurajala S, Curtis M, Eisenhaure TM, Arazi A, Fava A, Xiao Q, Mears J, Rovin B, Berthier CC, Zhao Y, Izmirly PM, Barnas JL, Hoover PJ, Peters M, Raychowdhury R, Horisberger A, Sakaue S, Furie RA, Belmont HM, Hildeman DA, Woodle ES, Dall'Era M, Putterman C, Kamen DL, McMahon MA, Grossman J, Kalunian KC, Hodgin JB, Payan-Schober F, Apruzzese W, Perlman H, Cuda CM, Wofsy D, Guthridge JM, Anolik JH, James JA; Accelerating Medicines Partnerships Rheumatoid Arthritis/Systemic Lupus Erythematosus; Rao DA, Davidson A, Petri MA, Buyon JP, Hacohen N, Diamond B, Raychaudhuri S.Sci Transl Med. 2026 Aug 19;18(863):eaec0512. doi: 10.1126/scitranslmed.aec0512. Epub 2026 Aug 19.PMID: 42616839
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Raparia C, Hoover P, Ai J, Clark M, Shah S; Accelerating Medicines Partnership (AMP): RA/SLE Network; Diamond B, Hacohen N, Arazi A, Davidson A.Ann Rheum Dis. 2026 Aug 13:S0003-4967(26)00435-8. doi: 10.1016/j.ard.2026.07.014. Online ahead of print.PMID: 42595656
Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression
Hoover PJ, Eisenhaure T, Hodgin J, Apruzzese W, Mears J, Peters M, Jones T, Shah SI, Kamal H, Leavitt R, Jackson SW, Danaher P, Rao DA, Xiao Q, Gurajala S, Fava A, Berthier CC, Horisberger A, Izmirly PM, Belmont HM, Clancy R, Furie R, Guthridge JM, Dall'Era M, Wofsy D, Kamen DL, Kalunian KC, McMahon MA, Grossman J, Payan-Schober F, Hildeman DM, Woodle ES, Putterman C, Kretzler M, Raychaudhuri S, James JA, Anolik J, Petri MA, Buyon JP, The Accelerating Medicines Partnership RA/SLE Network, Diamond B, Davidson A, Hacohen N, Arazi A. Ann Rheum Dis. 2026 Apr 28:S0003-4967(26)00149-4. doi: 10.1016/j.ard.2026.03.004. PMID: 42055919
Pregnancy loss due to early developmental defects in lupus mice expressing human TLR8
Naomi I Maria, Yunwei Xia, Chirag Raparia, Ke Lin, Shani Martinez, Zhengzi Yi, Weijia Zhang, Monowar Aziz, Ping Wang, Marta Guerra, Jane Salmon, Jenny L Sones, Arnon Arazi, Paul Hoover, Anne Davidson bioRxiv 2026.02.07.701591; Published in bioRxiv 2026. doi: https://doi.org/10.64898/2026.02.07.701591
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis
Hoover PJ, Raparia C, Lieb DJ, Tzur Y, Kang J, Arazi A, Leavitt R, Shah S, Simmons D, Li S, Peters M, Eisenhaure T, Cooper TJ, Gurajala SS, Xiao Q, Mishra R, Menon R, Kretzler M, Sonny A, Demeke D, Hodgin J, Guthridge J, Fava A, Clancy R, Putterman C, Izmirly P, Belmont HM, Kalunian K, Kamen D, Wofsy D, Buyon J, James JA, Petri M, Diamond B, Raychaudhuri S, Shen Orr SS, The Accelerating Medicines Partnership RA/SLE network, Hacohen N, Davidson A. J Exp Med. 2025 Nov 3;222(11):e20241873. doi: 10.1084/jem.20241873.
An atlas of healthy and injured cell states and niches in the human kidney
Blue B Lake, Rajasree Menon, Seth Winfree, Qiwen Hu, Ricardo Melo Ferreira, Kian Kalhor, Daria Barwinska, Edgar A Otto, Michael Ferkowicz, Dinh Diep, Nongluk Plongthongkum, Amanda Knoten, Sarah Urata, Laura H Mariani, Abhijit S Naik, Sean Eddy, Bo Zhang, Yan Wu, Diane Salamon, James C Williams, Xin Wang, Karol S Balderrama, Paul J Hoover, Evan Murray, Jamie L Marshall, Teia Noel, Anitha Vijayan, Austin Hartman, Fei Chen, Sushrut S Waikar, Sylvia E Rosas, Francis P Wilson, Paul M Palevsky, Krzysztof Kiryluk, John R Sedor, Robert D Toto, Chirag R Parikh, Eric H Kim, Rahul Satija, Anna Greka, Evan Z Macosko, Peter V Kharchenko, Joseph P Gaut, Jeffrey B Hodgin, KPMP Consortium, Michael T Eadon, Pierre C Dagher, Tarek M El-Achkar, Kun Zhang, Matthias Kretzler, Sanjay Jain Published in Nature, Volume 619, Pages 585–594 (2023), the research provides a detailed examination of the cellular landscape in the human kidney, paving the way for advancements in treatment strategies.
The immune cell landscape in the kidneys of patients with lupus nephritis
Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, and Diamond B, was published in Nat Immunol. 2019 07; 20(7):902-914. PMID: 31209404.
Send us a message using this form to discuss topics related to autoimmune diseases, including the role of macrophages, and various therapeutic targets. We are always looking for passionate post-docs, graduate students, research assistants, and undergrads. Please send your application and CV to phoover@bwh.harvard.edu.
Hale Building for Transformative Medicine at Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA 02115, USA
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.